Category Archives: Aphria

Exec: Aurora Cannabis to expand in US ‘moment it becomes allowable’

Canada’s leading medical cannabis company by revenue is ready to expand into the United States “the moment it becomes allowable,” one of its executives said at MJBizCon in Las Vegas. Marc Lakmaaker, vice president of Alberta-based Aurora Cannabis, discussed the multinational cannabis producer’s plan to enter the world’s largest economy when relevant laws allow it […]

Aphria seeks EU GMP certification prior to closing deal for German distributor

Aphria, one of Canada’s largest medical cannabis companies, aims to obtain an essential European quality standard certification before closing its deal to buy a large distributor of pharmaceutical products in Germany. Aphria announced last week its intention to buy Densborn, Germany-based CC Pharma for 24.5 million euros ($28 million) in cash on closing and another […]

Canadian marijuana producer Aphria aims to list on the New York Stock Exchange

Aphria, one of Canada’s largest cannabis producers, has filed documents with U.S. securities regulators signaling its intent to list its shares on the New York Stock Exchange. If approved, the Ontario-based company will join a growing list of Canadian cannabis firms turning to the top U.S. exchanges to tap the globe’s largest pool of institutional […]

Navy Capital leads $6 million funding round for Los Angeles cannabis firm

Los Angeles-based marijuana extracts firm Field is poised to expand into new markets after closing a $6 million funding round. The raise was led by: Cannabis investment fund Navy Capital under managing partners Sean Stiefel and John Kaden. MedReleaf executives Eitan Popper, Igor Gimelshtein and Tarik Ouass, who earlier this year sold the company to Aurora Cannabis for 3.2 billion Canadian dollars ($2.9 billion). […]

Medical marijuana firm raises $15M ahead of Australian Stock Exchange listing

An Australian medical marijuana company raised $20 million Australian dollars ($14.6 million) in its initial public offering and will begin trading Friday on the Australian Stock Exchange. Melbourne-based Althea Group will use the proceeds to fund a cannabis production facility, the Australian Associated Press reported. The company sold its shares for 20 Australian cents apiece, giving […]

How high is too high? Valuations continue to climb for Canadian cannabis businesses

As more cannabis companies go public and private businesses raise capital at an unprecedented clip, valuations have become a hot topic among industry observers, insiders and investors. That’s especially true in Canada, where a growing number of cannabis firms have fetched multibillion-dollar valuations in the public markets as they’ve hustled to become a top player […]